Unlock instant, AI-driven research and patent intelligence for your innovation.

Time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and preparation method thereof

A technology of time-resolved fluorescence and immunochromatography, which is applied in the field of clinical medical diagnosis, can solve the problems of reducing the false positive rate, achieve the effect of improving sensitivity, improving detection precision and accuracy, and eliminating the interference of samples

Inactive Publication Date: 2017-02-22
SHANGHAI UPPER BIO TECH PHARMA
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, normal serum / plasma values ​​of H-FABP are lower than those of myoglobin, thereby reducing the false positive rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and preparation method thereof
  • Time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and preparation method thereof
  • Time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] (1) Preparation of cTnI, H-FABP time-resolved fluorescent immunochromatographic test strips:

[0054] A. Preparation of detection line (T1, T2) solution: dilute cTnI monoclonal antibody and polyclonal antibody, H-FABP monoclonal antibody to 1-2 mg / ml with 10 times, 50 mM citrate solution;

[0055] B. Preparation of the quality control line (C) solution: dilute the rabbit IgG antibody to 1-2 mg / ml with 10-fold, 50 mM citrate solution;

[0056] On the bottom plate (1) with adhesive backing, adopt the overlapping method, first paste the nitrocellulose membrane (3), and then paste the Fusion5 membrane (2) and the absorbent paper ( 4). On the nitrocellulose membrane (3) and close to the Fusion5 membrane (2), draw T1 (H-FABP capture line (5)), T2 (cTnI capture line (6)), respectively, at the end close to the absorbent paper (4) Draw the C (rabbit IgG) line, and the intervals between T1, T2, and C are all 4mm.

[0057] At the T line, draw T1 and T2 respectively, and at the ...

Embodiment 2

[0060] Detection of cTnI, H-FABP time-resolved fluorescent immunochromatographic test strips

[0061] (1) Preparation of cTnI, H-FABP goat anti-rabbit time-resolved fluorescent microspheres

[0062] Dissolve time-resolved fluorescent microspheres (particle size about 200nm) in 100mM MES buffer (pH 6.0), add activator (NHS, 20mg / ml; EDC, 20mg / ml) to activate for 15 minutes; wash, centrifuge, Reconstitute the time-resolved fluorescent microspheres with 60mM boric acid buffer (pH 8.5), then add troponin I monoclonal antibody 2 to react for 2 hours (the mass ratio of microspheres to antibodies is 10mg:0.5mg); the reaction is completed Then add blocking agent (BSA, 100mg / ml) to block for 2 hours; after blocking, wash, centrifuge, redissolve with 60mM boric acid buffer (pH 8.5) and blocking agent (BSA, 100mg / ml) again, sonicate, make The microspheres are evenly dispersed in the buffer, and stored at 2-8°C in the dark.

[0063] The preparation process of fluorescent microspheres la...

Embodiment 3

[0069] Precision testing

[0070] With the test method in embodiment 2, test the mixed standard substance of cTnI, H-FABP respectively (the concentration of cTnI is 1 and 25ng / ml, the concentration of H-FABP is 10 and 80ng / ml), each standard substance is repeatedly detected Ten times, the specific detection values ​​are shown in Table 1 below.

[0071] Table 1 precision test result table

[0072]

[0073]

[0074] As can be seen from the data in Table 1, using the triple detection test strip of the present invention, the precision of cTnI and H-FABP are all less than 10%, fully meeting the requirement of POCT product precision less than 15%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of clinical medical diagnosis, and especially relates to a time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and a preparation method thereof. The reagent comprises a test strip and a fluorescent liquid, wherein the test strip includes a baseboard, Fusion5, a nitrocellulose membrane and an absorbent pad. Time-resolved fluorescence microspheres are used to improve the fluorescence intensity, reduce background signals and simultaneously detect the cTnI and the H-FABP in whole blood, serum or plasma only through using 10-20 [mu]L of a sample. The test strip has the advantages of convenience, fastness, simplicity in operation, short detection time, high specificity, high sensitivity and accurate detection result, and is suitable for rapid diagnosis of clinical POCT.

Description

technical field [0001] The invention belongs to the field of clinical medical diagnosis, and in particular relates to a time-resolved fluorescent immunochromatographic reagent for rapid and quantitative simultaneous detection of cTnI and H-FABP and a preparation method thereof. Background technique [0002] Cardiovascular disease is a serious disease that endangers human health and life, and has become the number one killer of human health in the 21st century. In August 2009, Bayer Pharmaceuticals reported at the annual meeting of the European Society of Cardiology that about 17.5 million people died of cardiovascular diseases in the world in 2005, and this number is expected to climb to 20 million in 2015, and about half of the cases occurred in the Asia-Pacific region. area. The improvement of living conditions and the change of lifestyle have made the risk of cardiovascular disease in Chinese people surpass that of developed countries such as the United States. [0003]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68G01N33/577G01N33/558G01N33/545G01N33/533
CPCG01N33/6893G01N33/533G01N33/54313G01N33/558G01N33/577G01N2333/47G01N2333/4712G01N2800/324
Inventor 朱传增石晓强朱奇朗安永君张蕾
Owner SHANGHAI UPPER BIO TECH PHARMA